JYPC signed a technology development contract with Hunan University of Traditional Chinese Medicine
I'm PortAI, I can summarize articles.
JYPC's wholly-owned subsidiary signed a technology development contract with Hunan University of Traditional Chinese Medicine to develop the innovative traditional Chinese medicine "Juanbi Lijie Qing Granules." In the contract, Hunan University of Traditional Chinese Medicine provides the traditional Chinese medicine prescription and technical support, while JYPC is responsible for pharmaceutical research, pharmacological and toxicological research, and clinical research, with the ultimate goal of obtaining the drug clinical trial approval notice
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments